Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Vu T. Nguyen
Preclinical Evaluation of the PARP Inhibitor, Olaparib, in Combination With Cytotoxic Chemotherapy in Pediatric Solid Tumors
Pediatric Blood and Cancer
Oncology
Child Health
Hematology
Perinatology
Medicine
Pediatrics
Related publications
ASP9853, an Inhibitor of Inducible Nitric Oxide Synthase Dimerization, in Combination With Docetaxel: Preclinical Investigation and a Phase I Study in Advanced Solid Tumors
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
The PARP Inhibitor AZD2281 (Olaparib) Induces Autophagy/Mitophagy in BRCA1 and BRCA2 Mutant Breast Cancer Cells
International Journal of Oncology
Cancer Research
Oncology
Safety, Pharmacokinetics, and Clinical Activity of Adavosertib in Combination With Chemotherapy in Asian Patients With Advanced Solid Tumors: Phase Ib Study
Targeted Oncology
Cancer Research
Oncology
Pharmacology
Surgical Management in Pediatric Malignant Solid Tumors
Journal of Nihon University Medical Association
Phase I Study to Assess the Safety and Tolerability of Olaparib in Combination With Bevacizumab in Patients With Advanced Solid Tumours
British Journal of Cancer
Cancer Research
Oncology
Preclinical Pharmacokinetics and Dosimetry Studies of [124i/131i]-Clr1404 for Treatment of Pediatric Solid Tumors in Murine Xenograft Models
Journal of Nuclear Medicine
Medicine
Nuclear Medicine
Radiology
Imaging
PET Imaging of PARP Expression Using [18F]olaparib
Journal of Nuclear Medicine
Medicine
Nuclear Medicine
Radiology
Imaging
A Quantitative Chemotherapy Genetic Interaction Map Reveals Factors Associated With PARP Inhibitor Resistance
Cell Reports
Biochemistry
Genetics
Molecular Biology
A Phase I Pharmacokinetic and Pharmacodynamic Study of the Farnesyl Transferase Inhibitor BMS-214662 in Combination With Cisplatin in Patients With Advanced Solid Tumors
Clinical Cancer Research
Cancer Research
Oncology
